These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The cytogenetics of haematological malignancies. Berger R Baillieres Clin Haematol; 1992 Oct; 5(4):791-814. PubMed ID: 1308165 [No Abstract] [Full Text] [Related]
6. [Cytogenetics of malignant hemopathies: achievements and perspectives]. Rochon M; Gyger M Union Med Can; 1983 May; 112(5):407-10. PubMed ID: 6879854 [No Abstract] [Full Text] [Related]
7. [Clinical application of the international histological and cytological classification of hematologic and lymphatic neoplasms]. Tomilov AF; Streneva TN; Belikov ES; Zubov NA; Shalaev VA Arkh Patol; 1982; 44(5):71-5. PubMed ID: 7115136 [TBL] [Abstract][Full Text] [Related]
8. Cytogenetic markers in hematoproliferative disorders. Fonatsch C Blut; 1985 Nov; 51(5):315-28. PubMed ID: 3864500 [TBL] [Abstract][Full Text] [Related]
9. [Vasculitis and malignant diseases]. Gran JT Tidsskr Nor Laegeforen; 1997 Apr; 117(11):1627-9. PubMed ID: 9198948 [TBL] [Abstract][Full Text] [Related]
10. [Incidence of mononuclear bone-marrow megakaryocytes in various hemopathies]. Simón R; Woessner S Sangre (Barc); 1988 Jun; 33(3):238-9. PubMed ID: 3175821 [No Abstract] [Full Text] [Related]
12. The use of cell markers in the study of human hematopoietic neoplasia. Raskind WH; Fialkow PJ Adv Cancer Res; 1987; 49():127-67. PubMed ID: 2890277 [No Abstract] [Full Text] [Related]
13. [Molecular cytogenetics in chronic lymphatic leukemia: differential diagnosis with other chronic B-lineage lymphoproliferative syndromes]. García Marco JA Sangre (Barc); 1999 Aug; 44(4):269-72. PubMed ID: 10589278 [No Abstract] [Full Text] [Related]
14. Cytogenetics. An evolving role in the diagnosis and treatment of cancer. Glassman AB Clin Lab Med; 1997 Mar; 17(1):21-37. PubMed ID: 9138897 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications. Panani AD Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090 [TBL] [Abstract][Full Text] [Related]
16. [Cytogenetics and hemopathies]. Berger R Nouv Rev Fr Hematol; 1972; 12(4):510-5. PubMed ID: 4264208 [No Abstract] [Full Text] [Related]
17. Marker chromosome 14q + in human cancer and leukemia. Mitelman F Adv Cancer Res; 1981; 34():141-70. PubMed ID: 7025591 [No Abstract] [Full Text] [Related]